Skip to main content

Table 2

From: TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model

Primary Antibody Vendor Catalog number Dilution
ERG 1/2/3 Santa Cruz Biotechnology sc-28,680 1:5000
AR (N-20) Santa Cruz Biotech sc-816 1:1000
GAPDH Santa Cruz Biotech sc-25,778 1:10000
AKR1C3 Sigma Aldrich A6229 1:1000
HSD3B1 Sigma Aldrich WH0003283M1 1:1000
HSD3B2 Sigma Aldrich SAB1402232 1:1000
Secondary Antibody Vendor Catalog number Dilution
Anti-rabbit IgG, HRP Cell Signaling Technology 7074S 1:5000
Anti-mouse IgG, HRP Cell Signaling Technology 7076S 1:5000